http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104918961-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8845066b8a149cf546de000251645fea
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-31
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-549
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-605
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-26
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-16
filingDate 2013-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e81f6bf5da02cf696b133de1b6b2ed7f
publicationDate 2015-09-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-104918961-A
titleOfInvention Improved peptide drugs for insulin resistance
abstract Described herein are methods of synthesis and therapeutic uses of covalently modified peptides and/or proteins. Covalently modified peptides and/or proteins allow for improved pharmaceutical properties of peptide and protein based therapies.
priorityDate 2012-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008299079-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011257096-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008268032-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407609183
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467144221
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466243348
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414121999
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465386693
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID163721974
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID147049323
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID149291024

Total number of triples: 36.